Phase I/II and pharmacologic study of irinotecan and carboplatin for patients with lung cancer.
Sato M, Ando M, Minami H, Ando Y, Ando M, Yamamoto M, Sakai S, Watanabe A, Ikeda T, Sekido Y, Saka H, Shimokata K, Hasegawa Y.
Sato M, et al. Among authors: watanabe a.
Cancer Chemother Pharmacol. 2001 Dec;48(6):481-7. doi: 10.1007/s002800100355.
Cancer Chemother Pharmacol. 2001.
PMID: 11800029
Clinical Trial.